On October 7, 2025, the official launch event of Avoran – a medicinal product for the treatment of migraine containing frovatriptan – took place in Bucharest. This event marks the beginning of Avoran’s expansion into the European markets, with Romania being the first country following its successful launch in Bulgaria in December 2023.
The event was held at the Grand Hotel Bucharest and brought together more than 350 healthcare professionals – 50 attending in person and over 300 joining online. During the event, participants learned about the therapeutic benefits of Avoran and the opportunities it offers for the treatment of migraine with or without aura.
In Romania, Avoran will be supported by an extensive medical promotion campaign as part of the long-term strategy to establish the product on the European market.